Real estate interests and insurance companies that administer National Flood Insurance Program policies are heaving a sigh of relief after Congress approved a last-minute deal to temporarily fund the federal government, keeping the NFIP in business—but only until Nov. 17.
An increasing number of finance chiefs are cutting their company’s spending plans as higher interest rates squeeze their bottom lines, according to a survey published Wednesday by Duke University’s Fuqua School of Business and the Federal Reserve Banks of Atlanta and Richmond.
While many employer plans cover the headline-grabbing Ozempic and similar drugs as a diabetes treatment, just 22% of U.S. employers cover any kind of prescription drugs for weight loss—for which Ozempic and cousins Wegovy and Rybelsus are increasingly prescribed.
The confidence of American consumers slipped this month, particularly about the future, as expectations persist that interest rates will remain elevated for an extended period.
The Louisiana State Medical Society currently expects to vote “no” on the proposed plan to convert Blue Cross and Blue Shield of Louisiana into a stock insurance company as part of the potential sale to Elevance Health, the society’s president says in a letter to state Commissioner of Insurance Jim Donelon.